Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Sep 10;9(3):52.
doi: 10.3390/jfb9030052.

Formulation and Evaluation of Silymarin-Loaded Chitosan-Montmorilloite Microbeads for the Potential Treatment of Gastric Ulcers

Ameya Sharma  1 , Vivek Puri  2 , Vandita Kakkar  3 , Inderbir Singh  4
Affiliations

Formulation and Evaluation of Silymarin-Loaded Chitosan-Montmorilloite Microbeads for the Potential Treatment of Gastric Ulcers

Ameya Sharma et al. J Funct Biomater. .

Abstract

Silymarin-loaded mucoadhesive microbeads of Chitosan-MMT were developed using the ionotropic gelation technique. Characterization of the microbeads was performed by DSC, XRD, SEM, and FTIR techniques. In vitro mucoadhesion and drug release studies; gastroprotective studies including the measurement of ulcerative index; the determination of gastric wall mucus; and the determination of percentage protection, biochemical, and histopathological studies were also performed. Microbeads batches were evaluated for particle size (120⁻140 µm), actual drug content, (49.36⁻58.18%) and entrapment efficiency (72.52⁻92.39%).Biochemical estimation of myeloperoxidase was found to be 0.10⁻0.75 µmoles/g/tissue. Significant reduction in the ulcerative index showed the gastroprotective effect of the formulation. Silymarin-loaded beads of Chitosan-MMT were found to exhibit good mucoadhesion and efficient release of the drug, and were found to be a promising drug carrier system for the treatment of gastric ulcers.

Keywords: Microbeads; chitosan; gastric ulcers; montmorillonite; silymarin.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Average diameter of Silymarin-loaded Chitosan-MMT microbeads of different batches.
Figure 2
Figure 2
Layout representing the FTIR spectra of CMMTB51, Silymarin, MMT, and Chitosan.
Figure 3
Figure 3
DSC thermogram of (a) drug, (b) CMMTB51, (c) MMT, and (d) Chitosan.
Figure 4
Figure 4
SEM images of formulated beads at different magnification value (a) at 95×, (b) 45×, (c) 1000×, and (d) 3000×.
Figure 5
Figure 5
X-ray Diffraction pattern of (a) Silymarin- and (b) Silymarin-loaded Chitosan-MMT beads.
Figure 6
Figure 6
In vitro release profile of Silymarin from different batches of microbeads.
See this image and copyright information in PMC

References

    1. Boddupalli B.M., Mohammed Z.N.K., Nath R.A. Mucoadhesive drug delivery system. J. Adv. Pharm. Technol. Res. 2010;1:381–387. doi: 10.4103/0110-5558.76436. - DOI - PMC - PubMed
    1. Ways T.M.M., Lau W.M., Khutoryanskiy V. Chitosan and its derivatives for application in mucoadhesive drug delivery system. Polymers. 2018;10:267. doi: 10.3390/polym10030267. - DOI - PMC - PubMed
    1. Salcedo I., Aguzzi C., Sandri S. In vitro biocompatibility and mucoadhesion of montmorillonite chitosan nanocomposite: A new drug delivery. Appl. Clay Sci. 2012;55:131–137. doi: 10.1016/j.clay.2011.11.006. - DOI
    1. Thakur G., Singh A., Singh I. Chitosan-Montmorillonite polymer composite: Formulation and evaluation of sustained release tablets of aceclofenac. Sci. Pharm. 2016;84:603–617. doi: 10.3390/scipharm84040603. - DOI - PMC - PubMed
    1. Xu Y., Ren X., Hanna M.A. Chitosan/clay nanocomposite film preparation and characterization. J. Appl. Polym. Sci. 2006;99:1684–1691. doi: 10.1002/app.22664. - DOI

LinkOut - more resources